LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 45 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,265,000 | -6.8% | 2,275,000 | -6.2% | 0.00% | – |
| Q3 2021 | $2,429,000 | +5.7% | 2,425,000 | +4.3% | 0.00% | – |
| Q2 2021 | $2,298,000 | -25.0% | 2,325,000 | -21.5% | 0.00% | – |
| Q1 2021 | $3,064,000 | +62.8% | 2,960,000 | +48.0% | 0.00% | – |
| Q4 2020 | $1,882,000 | -5.1% | 2,000,000 | -9.1% | 0.00% | – |
| Q3 2020 | $1,984,000 | -9.5% | 2,200,000 | -12.0% | 0.00% | – |
| Q2 2020 | $2,193,000 | +20.8% | 2,500,000 | +13.6% | 0.00% | – |
| Q1 2020 | $1,816,000 | +13.7% | 2,200,000 | +18.9% | 0.00% | – |
| Q4 2019 | $1,597,000 | +3.6% | 1,850,000 | 0.0% | 0.00% | – |
| Q3 2019 | $1,542,000 | -3.4% | 1,850,000 | 0.0% | 0.00% | – |
| Q2 2019 | $1,597,000 | – | 1,850,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $38,988,000 | 1.44% |
| Penn Mutual Asset Management, LLC | 1,204,000 | $1,174,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,148,000 | 0.96% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,006,000 | $9,832,000 | 0.23% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,431,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 20,353,000 | $19,882,000 | 0.21% |
| Wellesley Asset Management | 2,304 | $2,245,000 | 0.15% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,719,000 | 0.12% |
| SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,942,000 | 0.11% |
| Cutler Capital Management, LLC | 300,000 | $291,000 | 0.10% |